Access cutting-edge upper tract urothelial cancer treatment through this clinical trial at a research site in Aventura. Study-provided care at no cost to qualified participants.
Access upper tract urothelial cancer specialists in Aventura at no cost
This study follows strict safety protocols and ethical guidelines
All study-related upper tract urothelial cancer treatment provided free
This study will evaluate the efficacy and safety of UGN-104, a new formulation of UGN-101 (approved in the United States and Israel as JELMYTO \[mitomycin\] for pyelocalyceal solution), instilled in the upper urinary tract (UUT) of patients with low-grade upper tract urothelial cancer (LG-UTUC).
Sponsor: UroGen Pharma Ltd.
Check if you qualify for this upper tract urothelial cancer clinical trial in Aventura, FL
If you're searching for upper tract urothelial cancer treatment options in Aventura, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Aventura research site is actively enrolling participants for this clinical trial. You'll receive care from experienced upper tract urothelial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.